Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2CELLTRION HEALTHCARE CANADA Limited

02 3Janssen Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Coatings Trends
Not Confirmed
arrow
Coatings Trends
Not Confirmed

Infliximab

Brand Name : REMICADE

Patent Number : 2106299

Filing Date : 1992-03-18

Strength per Unit : 100mg / vial

Dosage Form : Lyophilized Powder for Injection

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2012-03-18

Date Granted : 2001-02-06

blank

02

arrow
Coatings Trends
Not Confirmed
arrow
Coatings Trends
Not Confirmed

Infliximab

Brand Name : REMICADE

Patent Number : 2324853

Filing Date : 1992-03-18

Strength per Unit : 100mg / vial

Dosage Form : Lyophilized Powder for Injection

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2012-03-18

Date Granted : 2011-06-14

blank

03

Janssen Inc.

arrow
Coatings Trends
Not Confirmed

Janssen Inc.

Country
arrow
Coatings Trends
Not Confirmed

Infliximab

Brand Name : REMICADE

Patent Number : 2261630

Filing Date : 1992-03-18

Strength per Unit : 100mg / vial

Dosage Form : Lyophilized Powder for Injection

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2017-08-01

Date Granted : 2012-12-04

blank

04

CELLTRION HEALTHCARE CANADA ...

arrow
Coatings Trends
Not Confirmed

CELLTRION HEALTHCARE CANADA Limited

Country
arrow
Coatings Trends
Not Confirmed

INFLIXIMAB

Brand Name : REMSIMA SC

Patent Number : 3028238

Filing Date : 2017-06-28

Strength per Unit : 120 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2037-06-28

Date Granted : 2024-01-02

blank

05

CELLTRION HEALTHCARE CANADA ...

arrow
Coatings Trends
Not Confirmed

CELLTRION HEALTHCARE CANADA Limited

Country
arrow
Coatings Trends
Not Confirmed

INFLIXIMAB

Brand Name : REMSIMA SC

Patent Number : 3028238

Filing Date : 2017-06-28

Strength per Unit : 120 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : SUBCUTANEOUS

Patent Expiration Date : 2037-06-28

Date Granted : 2024-01-02

blank